Clinical trial
Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation…
NCT00073970 · UNC Lineberger Comprehensive Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00073970 |
|---|---|
| Title | Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy |
| Official title | A Trial Of COX-2 Inhibitors In PSA Recurrence After Definitive Radiation Or Radical Prostatectomy For Prostate Cancer |
| Lead sponsor | UNC Lineberger Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | celecoxib |
| Enrollment | 37 |
| Start date | Apr 1, 2003 |
| Primary completion | Jun 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Dec 11, 2003 |
| Last update posted | May 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: